Barr Pharmaceuticals has signed a letter of intent to buy the rights to Organon's Mircette oral contraceptive for $142 million, while executing an end to patent litigation over a generic version of ...
CORONA, Calif., Dec. 29 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leader in generic and specialty branded pharmaceuticals, today announced ...
LONDON (MarketWatch) -- Dutch pharmaceuticals company Akzo Nobel NV and Savient Pharmaceuticals, Inc. on Friday said they have reached a settlement with Barr Laboratories, Inc. in a patent dispute ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The popularity of “the Pill” created ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results